SCHEDULE 13G/A: First Light, Arens Update AnaptysBio Stake to 3.12%

First Light Asset Management and its principal, Mathew P. Arens, have filed an amended Schedule 13G, reporting their aggregate beneficial ownership in AnaptysBio Inc. at 3.12%.

Summary

• First Light Asset Management, LLC beneficially owns 770,568 shares of AnaptysBio Inc. common stock, representing 2.78% of the class.
• Mathew P. Arens beneficially owns an aggregate of 864,618 shares of AnaptysBio Inc. common stock, representing 3.12% of the class.
• Mr. Arens's ownership includes 31,000 shares with sole voting and dispositive power, and 833,618 shares with shared voting and dispositive power.
• Mr. Arens controls First Light Asset Management, LLC as its managing member and majority owner, and is deemed a beneficial owner of the shares held by the Manager.
• The filing is an Amendment No. 2 to Schedule 13G, indicating an update to previously reported beneficial ownership.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of AnaptysBio Inc.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual report on beneficial ownership and does not contain performance or forward-looking statements that would indicate a positive or negative sentiment.

Positives

• First Light Asset Management, LLC and Mathew P. Arens maintain a significant, though non-controlling, stake in AnaptysBio Inc., indicating continued investment interest.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of beneficial ownership by an investment adviser and its principal. It does not provide insights into AnaptysBio Inc.'s operational performance or broader industry trends, but rather reflects an investment position by specific entities.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional and individual ownership stakes, which can influence market perception of institutional interest in AnaptysBio Inc.

Key Dates

Keywords

AnaptysBio Inc., First Light Asset Management, Mathew P. Arens, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser